Literature DB >> 18480421

Polydactyly in mice lacking HDAC9/HDRP.

Brad E Morrison1, Santosh R D'Mello.   

Abstract

Mice lacking histone deacetylase 9 (HDAC9) and its truncated variant, HDRP, exhibit post-axial polydactyly that manifests as an extra big toe on the right hind foot. Polydactyly in HDAC9/ HDRP knockout mice occurs with incomplete penetrance and affects both genders similarly. Because polydactyly can result from overactivity of sonic hedgehog (Shh) signaling, we investigated whether HDRP acted as a negative regulator of the Shh pathway. We find that Gli1, a transcription factor and downstream mediator of Shh signaling, is expressed at substantially higher levels in the feet of perinatal HDAC9/ HDRP-/- mice as compared with wild-type littermates. To more directly examine whether HDRP negatively-regulates Shh signaling we utilized cell lines that express components of the Shh pathway and that respond to the Shh agonist purmorphamine. We find that purmorphamine-mediated stimulation of Gli1 in the NIH 3T3 and HT22 cell lines is inhibited by the expression of HDRP. In HT22 cells, purmorphamine treatment leads to an increase in the rate of cell proliferation, which is also inhibited by HDRP. This inhibitory effect of HDRP on purmorphamine-mediated cell proliferation was also observed in primary cultures of glial cells. Although the mechanism by which it inhibits Gli1 induction and cell proliferation by purmorphamine is not clear, HDRP localizes to the nucleus suggesting it acts just upstream of Gli3 activation in the signaling cascade activated by Shh. Taken together our results suggest that HDRP acts as a negative regulator of the Shh pathway and that the absence of HDRP results in hyper-activation of this pathway resulting in polydactyly.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480421      PMCID: PMC2656257          DOI: 10.3181/0802-RM-48

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  34 in total

1.  Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb.

Authors:  B Wang; J F Fallon; P A Beachy
Journal:  Cell       Date:  2000-02-18       Impact factor: 41.582

2.  E2F family members are differentially regulated by reversible acetylation.

Authors:  G Marzio; C Wagener; M I Gutierrez; P Cartwright; K Helin; M Giacca
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

3.  Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP.

Authors:  S R D'Mello; C Galli; T Ciotti; P Calissano
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

4.  New insights into the problem of pattern regulation in the limb bud of the chick embryo.

Authors:  J W Saunders; M T Gasseling
Journal:  Prog Clin Biol Res       Date:  1983

5.  Myf5 is a direct target of long-range Shh signaling and Gli regulation for muscle specification.

Authors:  Marcus K Gustafsson; Hua Pan; Deborah F Pinney; Yongliang Liu; Anna Lewandowski; Douglas J Epstein; Charles P Emerson
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

Review 6.  Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells.

Authors:  P A Marks; V M Richon; R A Rifkind
Journal:  J Natl Cancer Inst       Date:  2000-08-02       Impact factor: 13.506

7.  The amino-terminal region of Gli3 antagonizes the Shh response and acts in dorsoventral fate specification in the developing spinal cord.

Authors:  Néva P Meyer; Henk Roelink
Journal:  Dev Biol       Date:  2003-05-15       Impact factor: 3.582

8.  Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase.

Authors:  M Kijima; M Yoshida; K Sugita; S Horinouchi; T Beppu
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

9.  Sonic hedgehog signaling regulates Gli3 processing, mesenchymal proliferation, and differentiation during mouse lung organogenesis.

Authors:  Yina Li; Huimin Zhang; Seung Cheol Choi; Ying Litingtung; Chin Chiang
Journal:  Dev Biol       Date:  2004-06-01       Impact factor: 3.582

10.  Large-scale double-staining of rat fetal skeletons using Alizarin Red S and alcian blue.

Authors:  A D Young; D E Phipps; A B Astroff
Journal:  Teratology       Date:  2000-04
View more
  15 in total

1.  Genetic and maternal effects on valproic acid teratogenesis in C57BL/6J and DBA/2J mice.

Authors:  Chris Downing; Jami Biers; Colin Larson; Alexi Kimball; Hali Wright; Takamasa Ishii; David Gilliam; Thomas Johnson
Journal:  Toxicol Sci       Date:  2010-05-10       Impact factor: 4.849

2.  New role for histone deacetylase 9 in atherosclerosis and inflammation.

Authors:  Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-09       Impact factor: 8.311

3.  Histone deacetylase 9 (HDAC9) regulates the functions of the ATDC (TRIM29) protein.

Authors:  Zhigang Yuan; Lirong Peng; Rangasudhagar Radhakrishnan; Edward Seto
Journal:  J Biol Chem       Date:  2010-10-14       Impact factor: 5.157

4.  Expression of HDAC9 in lung cancer--potential role in lung carcinogenesis.

Authors:  Koji Okudela; Hideaki Mitsui; Takehisa Suzuki; Tetsukan Woo; Yoko Tateishi; Shigeaki Umeda; Yuichi Saito; Michihiko Tajiri; Munetaka Masuda; Kenichi Ohashi
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

5.  Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development.

Authors:  Qiang Cao; Shunxing Rong; Joyce J Repa; Richard St Clair; John S Parks; Nilamadhab Mishra
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-07-17       Impact factor: 8.311

6.  Overexpression of HDAC9 promotes oral squamous cell carcinoma growth, regulates cell cycle progression, and inhibits apoptosis.

Authors:  Bhawna Rastogi; Satish K Raut; Naresh K Panda; Vidya Rattan; Bishan D Radotra; Madhu Khullar
Journal:  Mol Cell Biochem       Date:  2016-03-18       Impact factor: 3.396

7.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

8.  Allele-specific imbalance mapping identifies HDAC9 as a candidate gene for cutaneous squamous cell carcinoma.

Authors:  Jessica L Fleming; Amy M Dworkin; Dawn C Allain; Soledad Fernandez; Lai Wei; Sara B Peters; O Hans Iwenofu; Katie Ridd; Boris C Bastian; Amanda Ewart Toland
Journal:  Int J Cancer       Date:  2013-07-16       Impact factor: 7.396

9.  Coding exons function as tissue-specific enhancers of nearby genes.

Authors:  Ramon Y Birnbaum; E Josephine Clowney; Orly Agamy; Mee J Kim; Jingjing Zhao; Takayuki Yamanaka; Zachary Pappalardo; Shoa L Clarke; Aaron M Wenger; Loan Nguyen; Fiorella Gurrieri; David B Everman; Charles E Schwartz; Ohad S Birk; Gill Bejerano; Stavros Lomvardas; Nadav Ahituv
Journal:  Genome Res       Date:  2012-03-22       Impact factor: 9.043

10.  HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation.

Authors:  Rui Yang; Yanan Wu; Mei Wang; Zhongfeng Sun; Jiahua Zou; Yundong Zhang; Hongjuan Cui
Journal:  Oncotarget       Date:  2015-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.